Company: INSP
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0001609550-25-000053
Chunk: 11

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-11-03
Form: 10-Q
Item: Part II, Item 5
Chunk 11
---
Item 5.    Other Information.

(a)  None.

(b)  None.

43

Table of Contents

(c)  Adoption or Termination of Trading Arrangements by Directors and Executive Officers

NameTitleActionRule 10b5-1Adoption/ Termination DateAggregate Number of Shares of Common Stock to be SoldExpiration DateShawn T McCormickDirectorAdoptAugust 29, 20256,200(1)August 17, 2026(1) This number includes shares of our common stock issuable pursuant to unvested restricted stock units (“RSU”) that are scheduled to vest during the term of the 10b5-1 plan, subject to time-based vesting conditions set forth in the applicable RSU award agreement.

There were no other "Rule 10b5-1 trading arrangements" or "non-Rule 10b5-1 trading arrangements," as each term is defined in Item 408(a) of Regulation S-K, adopted, modified or terminated by the Company’s directors or "officers" (as defined in Rule 16a-1(f) of the Exchange Act) during the three months ended September 30, 2025.

44